Status:
COMPLETED
Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID
Lead Sponsor:
Poitiers University Hospital
Conditions:
Identification of the Mother or Fetus Contamination by SARS Cov-2
Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father
Eligibility:
All Genders
Phase:
NA
Brief Summary
Maternal-fetal transmission in the second or third trimester of pregnancy of the SARS-COV-2 virus could explain some late fetal losses. Finding a cause in the context of fetal loss is essential for p...
Eligibility Criteria
Inclusion
- Major patient
- Patient with late spontaneous abortion (≥15 weeks of gestation)
- Benefiting from a Social Security scheme
- Patient who consented to participate in the study
- Free subject, without tutorship, curatorship or subordination
Exclusion
- Persons not benefiting from a Social Security scheme or not benefiting from it through a third party.
- Concurrent participation in another clinical research study.
Key Trial Info
Start Date :
May 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 17 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04387253
Start Date
May 23 2020
End Date
June 17 2022
Last Update
July 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Poitiers
Poitiers, France, 86000